Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
907,287
-
Share change
-
-1,735,528
-
Total reported value
-
$15,867,000
-
Price per share
-
$17.48
-
Number of holders
-
7
-
Value change
-
-$2,787,595
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) as of Q2 2014
As of 30 Jun 2014,
REDHILL BIOPHARMA LTD - SPONSORED ADS (RDHL) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
907,287 shares.
The largest 7 holders included
ORBIMED ADVISORS LLC, Broadfin Capital, LLC, GOLDMAN SACHS GROUP INC, MONETARY MANAGEMENT GROUP INC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, and Tower Research Capital LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.